Prognos Health team members Peter Pancione and Jennifer Ferrer will be representing Prognos Oncology at ASCO (#ASCO24) next week in Chicago! We're excited to connect with fellow oncology professionals and showcase our innovative solutions for supporting complex clinical populations, including our newly launched oncology offerings designed to more precisely target HCPs and improve patient outcomes. Are you attending ASCO? Let's connect! Drop a comment below or book at meeting time with the Prognos team: https://lnkd.in/eD3QB89B #oncology #asco #asco24 #complexpatients #PrognosHealth
Prognos Health’s Post
More Relevant Posts
-
📈 Excitement builds as #ASCO24 opens! American Society of Clinical Oncology (ASCO) conversations among HCPs🩺 on X increase rapidly 🚀 as they anticipate educational sessions, share event invitations and repost abstracts on #prostatecancer, #lungcancer, #kidneycancer, and more! Follow us for exclusive live updates from healthcare professionals attending ASCO over the next couple of days #ASCO24 #Oncology
-
-
Unlock the latest insights into European oncology care with real-world analyses from physician-supplied data. Download a Sample TherapyMonitor Report and tap into exclusive European Oncology Analytics Data now: https://ow.ly/vb4450Spsr8 #Oncology #HealthcareAnalytics #RealWorldData
-
-
Are you attending #ASCO next week? If so, and want to learn more about Inizio , do stop by our booth to meet the team. A quick snapshot, in the last 2 years, we have... ✅️ Supported 328 NMEs ✅️ Supported 50% of US new product launches ✅️ Supported 100% of the top oncology brands globally ✅️ Supported 95% of the top 20 brands globally ✅️ Supported 100% of the top 20 pharma globally We're 12,000 pharma and life sciences experts across 50 markets globally 🌎, dedicated to supporting every pivotal step of bringing new medicines 💊 to market and improving patient access and outcomes ❤️🩹 #ASCO24 #ReimagineHealth #ConnectedCapabilities #Commercialization #ProductLaunch #DrugDevelopment #Oncology #Biopharma #Biotech
Next week, we will be heading to the 2024 ASCO® Annual Meeting. Be sure to stop by booth 37157 to discuss how we can support you in getting the right treatments to the right patients, faster. You can find some of the team featured below 👇 Ryan Quigley Dean McAlister Lucy MacLauchlan Steve Cottrell Charlotte Turnier (Servan) John Burke Learn more about our oncology expertise here: https://lnkd.in/ggTHcREU #ASCO24 #Oncology #ReimagineHealth #Healthcare #Biopharma
-
-
Project Manager Leader | Expertise in Clinical Research, M&A Integrations, and Process Improvement | Skilled in Financial Management, Cross-Functional Team Leadership, and Compliance | ACRP-PM & CCRC Certified
If you are like me and cancer has somehow touched your life-It is easy to see why I’m so passionate about the research that we get to do. Oncology research is day by day, making big and impactful changes to the quality of care, treatment options, and ability to prolong progression free survival in so many cancer stages and tumor types, alike. Being such a small, but integral part of these every day changes, plus being able to contribute my ideas and experiences with the hope that it in some way continues to move Oncology clinical research in a forward direction. Improving not only the sites ability to succeed, but also the patient’s ability to have more access to clinical trials. #seeyouthere #scrsoncology
SCRS Oncology Summit is just around the corner and we are looking forward to seeing you there! Senior Operations Manager Courtney Alexander, CCRC, ACRP-PM will be speaking at two sessions this year, and with her wealth of #oncology #clinicaltrial knowledge, you won't want to miss them. Catch her Wednesday, April 10th at 11:15 AM during "Leveraging Data for Enhanced Oncology Trial Opportunities", and later that afternoon at 3:00 PM for "Unveiling Hidden Costs: Empowering Oncology Sites for Trial Success." cc: Society for Clinical Research Sites (SCRS) #clinicalresearch #scrsoncology
-
-
Following the introduction to the experts within our oncology clinical development team, we are excited to highlight the exceptional work they do every day. This case study demonstrates how our bespoke team at tranScrip empowered our client to expertly interpret and utilise Phase I data, establishing a robust foundation for subsequent clinical trials and successful market entry. Together, we are advancing the future of oncology care. #CaseStudy #Oncology #DrugDevelopment #ClinicalTrials
-
Access real-world analyses drawn from the latest, longitudinal, physician-supplied data on oncology care in Europe. Download a Sample TherapyMonitor Report and Access European Oncology Analytics Data: https://ow.ly/EAxk50Sfq2E #Oncology #HealthcareAnalytics #RealWorldData
-
-
ADVI Health senior advisor, Michael Kolodziej, MD, was recently featured in JCO Oncology Practice, an American Society of Clinical Oncology (ASCO) publication, for his article on private payers and #cancercare. The article discusses the significant changes in the United States #healthcare system over the past 10 years, particularly in cancer care and reimbursement models, highlighting missed opportunities in value-based #oncology programs and the oversized influence of the Oncology Care Model (OCM). Learn more and read the article: https://lnkd.in/g4EzXiQQ
-
🔑 "The key to advancing precision oncology is to democratize the data." 🔑 Stacy Hurt, Parexel's Chief Patient Officer and a stage 4 cancer survivor, highlights three things we MUST do to ensure all patients can potentially benefit from precision oncology in our New Medicines, Novel Insights report: https://lnkd.in/e-3jXjq2 #PatientData #Oncology #NovelInsights
-
🔑 "The key to advancing precision oncology is to democratize the data." 🔑 Stacy Hurt, Parexel's Chief Patient Officer and a stage 4 cancer survivor, highlights three things we MUST do to ensure all patients can potentially benefit from precision oncology in our New Medicines, Novel Insights report: https://lnkd.in/e-3jXjq2 #PatientData #Oncology #NovelInsights
-
🔑 "The key to advancing precision oncology is to democratize the data." 🔑 Stacy Hurt, Parexel's Chief Patient Officer and a stage 4 cancer survivor, highlights three things we MUST do to ensure all patients can potentially benefit from precision oncology in our New Medicines, Novel Insights report: https://lnkd.in/e-3jXjq2 #PatientData #Oncology #NovelInsights
